H6H
PCRX icon

Hightower 6M Holding’s Pacira BioSciences PCRX Stock Holding History

Hightower 6M Holding’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,294
Closed -$251K – 374
2022
Q1 		$251K Buy
+3,294
New +$220K 0.02% 216

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Hightower 6M Holding's PCRX Position: Q2 2022 in Review

Hightower 6M Holding sold out of Pacira BioSciences (PCRX) in Q2 2022, closing a stake of 3,294 shares — an estimated $251K sold.

Hightower 6M Holding first reported a position in PCRX in Q1 2022 and held it in 1 quarter. The position peaked at $251K in Q1 2022. 284 funds tracked by Wall St. Rank hold PCRX as of Q2 2022.

  • Hightower 6M Holding reported no remaining Pacira BioSciences position as of Q2 2022 after selling out during the quarter.
  • Hightower 6M Holding sold 3,294 Pacira BioSciences shares in Q2 2022, an estimated $251K.
  • Hightower 6M Holding first reported a position in Pacira BioSciences in Q1 2022 and held it in 1 quarter.
  • Hightower 6M Holding's Pacira BioSciences position peaked at $251K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2022.

Based on Hightower 6M Holding's 13F filing for Q2 2022, filed 27 Jul 2022.